Jonathan Violin - 23 May 2024 Form 4 Insider Report for Dianthus Therapeutics, Inc. /DE/ (DNTH)

Role
Director
Signature
/s/ Adam Veness, as attorney-in-fact for Jonathan Violin
Issuer symbol
DNTH
Transactions as of
23 May 2024
Net transactions value
$0
Form type
4
Filing time
28 May 2024, 20:02:21 UTC
Previous filing
13 Sep 2023
Next filing
06 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNTH Stock Option (Right to Buy) Award $0 +11,000 $0.000000 11,000 23 May 2024 Common Stock 11,000 $21.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.